Petros Pharmaceuticals
NASDAQ: PTPI
Healthcare
Drug Manufacturers - Specialty & Generic
Rank
#47605
Market Cap
533,049
Volume
18.22 M
Price
0.25
Change (%)
7.78%
Country or region
United States
United States
Petros Pharmaceuticals's latest marketcap:
533,049
As of May 2, 2025, Petros Pharmaceuticals's market capitalization has reached $533,049. According to our data, Petros Pharmaceuticals is the 47605th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 533,049 |
| Revenue (ttm) | 5.11 M |
| Net Income (ttm) | -26,797,159 |
| Shares Out | 2.14 M |
| EPS (ttm) | -83.47 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | May 14, 2025 |
Market Cap Chart
Data Updated: May 2, 2025
Petros Pharmaceuticals's yearly market capitalization.
Petros Pharmaceuticals has seen its market value drop from $42.71 M to $2.25 M since 2020, representing a total decrease of 94.74% and an annual compound decline rate (CAGR) of 49.55%.
| Date | Market Cap | Change (%) |
|---|---|---|
| April 21, 2025 | $2.25 M | -43.02% |
| December 31, 2024 | $3.94 M | 27.11% |
| December 29, 2023 | $3.10 M | -35.68% |
| December 30, 2022 | $4.82 M | -92.98% |
| December 31, 2021 | $68.71 M | 60.87% |
| December 31, 2020 | $42.71 M |
Company Profile
Frequently Asked Questions
As of May 2, 2025, Petros Pharmaceuticals (including the parent company, if applicable) has an estimated market capitalization of $533,049 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
Petros Pharmaceuticals global market capitalization ranking is approximately 47605 as of May 2, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.
Stock Detail
| Country or region | United States |
| Founded | 2020 |
| IPO Date | n/a |
| Employees | 18 |
| CEO | |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Address |
